Disease/Infection News

RSS

Bacterium that causes gum disease delivers one-two punch by triggering protective proteins in oral cavity

The newly discovered bacterium that causes gum disease delivers a one-two punch by also triggering normally protective proteins in the mouth to actually destroy more bone, a University of Michigan study found.

12 Jun 2013

Background mortality rates can be used to communicate vaccine safety risks

In a study using the Vaccine Safety Datalink (VSD), investigators analyzed four years of data and determined that background mortality rates (rates of death irrespective of cause) are crucial in interpreting the numbers of deaths following vaccination.

12 Jun 2013

Study shows iron-uptake receptor plays a role in HCV infection

Hepatitis C virus (HCV) infects more than 170 million people worldwide. Approximately 80 percent of infections lead to chronic illness including fibrosis, cirrhosis, cancer and also hepatic iron overload.

11 Jun 2013

Medicago gets Health Canada clearance to initiate Phase II clinical trial for H5N1 vaccine

Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced it has received clearance by Health Canada to initiate its Phase II dose-sparing clinical trial for an H5N1 Avian Influenza VLP vaccine candidate ("H5N1 vaccine").

11 Jun 2013

Study finds only 5% of US wash hands long enough to kill germs

A new study by Michigan State University researchers found that only 5 percent of people who used the bathroom washed their hands long enough to kill the germs that can cause infections.

11 Jun 2013

Drug targeting of phages could offer a potential new path to mitigate antibiotic resistance

Bacteria in the gut that are under attack by antibiotics have allies no one had anticipated, a team of Wyss Institute scientists has found. Gut viruses that usually commandeer the bacteria, it turns out, enable them to survive the antibiotic onslaught, most likely by handing them genes that help them withstand the drug.

11 Jun 2013

Study explores various strategies, suggests cost-effective options for HIV testing in India

In India most people who are HIV positive don't know it, yet testing and treatment are relatively cheap and available. It would therefore meet international standards of cost-effectiveness - and save millions of lives for decades - to test every person in the billion-plus population every five years according to a new study published in the journal PLoS One.

11 Jun 2013

Small hospitals have higher rate of ventilator-associated pneumonia

Ventilator-associated pneumonia is one of the most frequent healthcare-associated infections found in intensive-care units. New research on the prevalence of VAP in community hospitals shows small hospitals (less than 30,000 patient-days/year) have a higher rate of VAP than their larger counterparts, despite less use of ventilators.

11 Jun 2013

3 out of 20 GI endoscopes used for screening harbor unacceptable levels of "bio dirt"

Three out of 20 flexible gastrointestinal (GI) endoscopes used for screening were found to harbor unacceptable levels of "bio dirt" - cells and matter from a patient's body that could pose potential infection risk -- according to a study of endoscopes used at five hospitals across the U.S.

10 Jun 2013

Mandatory influenza vaccination does not lead to excessive voluntary termination

Mandatory influenza (flu) vaccination, as a condition of employment, did not lead to excessive voluntary termination, according to a four-year analysis of vaccination rates at Loyola University Medical Center in Maywood, IL.

10 Jun 2013

BioLineRx signs out-licensing agreement with CTTQ to develop, commercialize Hepatitis C drug

BioLineRx, a biopharmaceutical development company, announced today that it has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd., the leading Chinese pharmaceutical company in the liver disease therapeutic area, for the development and commercialization of BL-8030, an orally available treatment for the Hepatitis C virus.

10 Jun 2013

NanoViricides files Orphan Drug application with FDA for DengueCide

NanoViricides, Inc. announced today that it has filed an Orphan Drug application with the Office of Orphan Product Development of the US FDA for DengueCide, its drug candidate for the treatment of dengue and dengue hemorrhagic fever.

10 Jun 2013

New revolutionary HIV test provides results in one minute

On Saturday, June 8th, AIDS Healthcare Foundation (AHF) will make history as the first HIV testing program in New York City to use a revolutionary HIV test that provides results to people in just one minute.

7 Jun 2013

Video promotes awareness about safe injection practices

A video depicting an animated man's harrowing experience with the healthcare system, including an avoidable unsafe injection, is the grand prize winner of the third annual Film Festival at the 40th Annual Conference of the Association for Professionals in Infection Control and Epidemiology (APIC).

7 Jun 2013

New Australian research shows evidence for pre-birth programming of food allergies

Among the many new findings presented at the EAACI-WAO World Allergy and Asthma Congress 2013 in Milan from 22-26 June 2013 is new Australian research providing proof for pre-birth programming of food allergies, showing that prenatal environmental factors may already determine predispositions for food allergies rather than only genetic factors.

7 Jun 2013

Available drugs may have a dramatic impact on children stricken with Tay-Sachs disease

A team of researchers has made a significant discovery which may have a dramatic impact on children stricken with Tay-Sachs disease, a degenerative and fatal neurological condition that often strikes in the early months of life.

7 Jun 2013

HSV-1 exploits immune system receptor to boost infectivity and cause disease

Researchers at the University of California, San Diego School of Medicine and colleagues report that the herpes simplex virus type-1 (HSV-1), which affects an estimated 50 to 80 percent of all American adults, exploits an immune system receptor to boost its infectivity and ability to cause disease.

7 Jun 2013

New comprehensive effort to model how humans respond to viral pathogens

In an effort to sort out why some viruses such as influenza, Ebola and West Nile are so lethal, a team of U.S. researchers plans a comprehensive effort to model how humans respond to these viral pathogens.

7 Jun 2013

Low levels of vitamin D associated with high levels of hepatitis B virus replication

Researchers from Germany have found that low levels of vitamin D are associated with high levels of hepatitis B virus replication. Findings published online in Hepatology, a journal of the American Association for the Study of Liver Diseases, suggest seasonal fluctuations in vitamin D and HBV levels point to a link in these variables among patients with chronic HBV.

6 Jun 2013

Social networks are tools to fight against infectious diseases in wild chimpanzees

Many think of social networks in terms of Facebook friends and Twitter followers, but for recent University of Georgia doctoral graduate Julie Rushmore, social networks are tools in the fight against infectious diseases.

6 Jun 2013

Disease/Infection News

Bacterium that causes gum disease delivers one-two punch by triggering protective proteins in oral cavity

Background mortality rates can be used to communicate vaccine safety risks

Study shows iron-uptake receptor plays a role in HCV infection

Medicago gets Health Canada clearance to initiate Phase II clinical trial for H5N1 vaccine

Study finds only 5% of US wash hands long enough to kill germs

Drug targeting of phages could offer a potential new path to mitigate antibiotic resistance

Study explores various strategies, suggests cost-effective options for HIV testing in India

Small hospitals have higher rate of ventilator-associated pneumonia

3 out of 20 GI endoscopes used for screening harbor unacceptable levels of "bio dirt"

Mandatory influenza vaccination does not lead to excessive voluntary termination

BioLineRx signs out-licensing agreement with CTTQ to develop, commercialize Hepatitis C drug

NanoViricides files Orphan Drug application with FDA for DengueCide

New revolutionary HIV test provides results in one minute

Video promotes awareness about safe injection practices

New Australian research shows evidence for pre-birth programming of food allergies

Available drugs may have a dramatic impact on children stricken with Tay-Sachs disease

HSV-1 exploits immune system receptor to boost infectivity and cause disease

New comprehensive effort to model how humans respond to viral pathogens

Low levels of vitamin D associated with high levels of hepatitis B virus replication

Social networks are tools to fight against infectious diseases in wild chimpanzees

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News